Oncoinvent ASA (OSL:ONCIN)
Norway flag Norway · Delayed Price · Currency is NOK
141.00
+6.50 (4.83%)
Sep 14, 2026, 1:10 PM CET

Oncoinvent ASA Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Oncoinvent ASA stock has a consensus rating of "Strong Buy" and an average price target of kr 112.50. The average 1-year stock price forecast is 20.21% lower than the current stock price, while the lowest is kr 110.00 (-21.99%) and the highest is kr 115.00 (-18.44%).

Price Target: kr 112.50 (-20.21%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Pricekr 110.00kr 112.50kr 112.50kr 115.00
Change-21.99%-20.21%-20.21%-18.44%

Analyst Ratings

The average analyst rating for Oncoinvent ASA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Apr '26Aug '26
Strong Buy122
Buy000
Hold000
Sell000
Strong Sell000
Total122

Financial Forecast

Revenue This Year
18.50M
from 28.07M
Decreased by -34.09%
Revenue Next Year
12.00M
from 18.50M
Decreased by -35.14%
EPS This Year
-33.52
EPS Next Year
-19.59
from -33.52
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
11.08M6.28M5.79M8.10M28.07M18.50M
Revenue Growth
6.80%-43.31%-7.85%39.95%246.40%-34.09%
Operating Income
-80.83M-110.61M-147.43M-141.02M-158.33M-154.00M
Net Income
-80.29M-106.28M-143.62M-140.20M-155.07M-152.00M
EPS
------33.52
Free Cash Flow
--52.26M-110.11M-34.76M-85.19M-160.50M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NOK.

Revenue Forecast

Revenue202620272028
High21.0M
Avg18.5M
Low16.0M

Revenue Growth

Revenue Growth202620272028
High
-25.2%
Avg
-34.1%
Low
-43.0%

EPS Forecast

EPS202620272028
High-29.92
Avg-33.52
Low-37.12

EPS Growth

EPS Growth20272028
High-
Avg-
Low-